U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07178340) titled 'Phase II Clinical Study for HER2-negative Hepatoid Adenocarcinoma of Stomach' on Sept. 10.
Brief Summary: The goal of this clinical trial is to learn if treatment modality including albumin-bound paclitaxel, oxaliplatin, tegafur,gimeracil and oteracil porassium capsules (SOX) and sintilimab works to treat locally advanced HER2-negative hepatoid adenocarcinoma of stomach. It will also learn about the safety of this modality. The main aim it aims to achieve are:
* To evaluate the perioperative efficacy of albumin-bound paclitaxel combined with sintilimab and SOX in the treatment of locally advanced HER2-negative hepatoid adenocarcin...